buthionine sulfoximine has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, H; Hirano, M; Ikeda, M; Kiriyama, T; Ueno, S | 1 |
| Heller, A; Kang, UJ; Nakamura, K; Won, L | 1 |
2 other study(ies) available for buthionine sulfoximine and Parkinsonian Disorders
| Article | Year |
|---|---|
Naturally- and experimentally-designed restorations of the Parkin gene deficit in autosomal recessive juvenile parkinsonism.
Topics: Aged; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Cyclin E; DNA Damage; Exons; Female; Fibroblasts; Gene Deletion; Humans; Male; Oligonucleotides, Antisense; Open Reading Frames; Oxidative Stress; Parkinsonian Disorders; SKP Cullin F-Box Protein Ligases; Transfection; Ubiquitin-Protein Ligases | 2010 |
Preferential resistance of dopaminergic neurons to glutathione depletion in a reconstituted nigrostriatal system.
Topics: Animals; Buthionine Sulfoximine; Catecholamines; Cell Aggregation; Cells, Cultured; Dopamine; Female; Fetus; Glutathione; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Degeneration; Neural Pathways; Neuroglia; Neurons; Parkinsonian Disorders; Pregnancy; Substantia Nigra; Time Factors | 2000 |